Chimera viruses can help the fight against lymphomas

September 15, 2017, Instituto de Medicina Molecular
Mice spleen cells (blue) infected with the chimera kaposi virus showing the LANA protein (red). Credit: Pedro Simas Lab, iMM Lisboa

Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

There are several types of herpes able to infect humans, such as herpes simplex, chickenpox, cytomegalovirus, Epstein-Barr and Kaposi sarcoma herpesvirus. One of the main characteristics of herpesviruses is their ability to infect their hosts for life, and in a small percentage of these people, the development of cancer.

Cancers associated with Kaposi virus infection have an Achilles heel: Cell viability is directly dependent on the survival of the virus, which means that if the virus were eliminated, cancer cells would no longer proliferate, hence, the cancer would be cured.

In collaboration with a team from Harvard Medical School, researchers led by Pedro Simas (iMM) and Kenneth Kaye (Harvard) studied a protein of the Kaposi virus vital for maintaining infection. Without this protein, called LANA, the virus loses its ability to cause .

The team found that when LANA is cloned into a virus similar to Kaposi, but which infects mice instead of humans, it preserves its functionality. This finding came as a surprise, since it was assumed that as a consequence of the evolutionary divergence between human and other animal viruses, the genes that code for LANA could not be switched.

However, the work now published in Plos Pathogens showed that LANA's functional mechanisms are preserved even though there are more than 60 million years of evolutionary divergence between the human Kaposi sarcoma herpesvirus and its rodent homologue.

These findings allowed researchers to create a chimera virus—a mouse virus with a human viral gene that can be used to test molecules that inhibit human LANA protein in an animal model of disease, treating not only human but also its associated cancers. These molecules could hopefully be used in the future as drugs to treat Kaposi virus-associated lymphomas.

"In addition to Kaposi virus, the same experimental strategy to create chimera viruses, previously thought to be theoretically nonviable, can now be used for other viruses that use proteins similar to LANA, such as the Epstein-Barr virus, which infects greater than 90 percent of the world population or the human papillomavirus responsible for cervical cancers," said Pedro Simas.

Explore further: New infections cause dormant viruses to reactivate

More information: Aline C. Habison et al, Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006555

Related Stories

New infections cause dormant viruses to reactivate

July 31, 2014
The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

Scientists identify possible key in virus, cancer research

August 27, 2015
Florida State University researchers have taken a big step forward in the fight against cancer with a discovery that could open up the door for new research and treatment options.

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.